logo

For the Inventor, By the Inventor

Scarsdale, NY, United States of America

Owen Anthony O'Connor

This inventor holds 12 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Columbia University, Sloan-Kettering Institute for Cancer Research. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Owen Anthony O'Connor. Retrieved from https://idiyas.com/inventor/owen-anthony-o-connor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 75.0


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal7 out of 2,554 
 
Columbia University
 patents
silverMedal5 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents

Years Active: 2009-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12239618 - Histone acetyltransferase activators and compositions and uses thereof (2025-03-04),
2. 11597933 - Combination therapy of lymphoma (2023-03-07),
3. 11406608 - Histone acetyltransferase activators and compositions and uses thereof (2022-08-09),
4. 11191768 - Histone acetyltransferase activators and uses thereof (2021-12-07),
5. 10882863 - Compounds for reducing c-Myc in c-Myc overexpressing cancers background (2021-01-05),
6. 10653648 - Histone acetyltransferase activators and compositions and uses thereof (2020-05-19),
7. 9896420 - N-quinolin-benzensulfonamides and related compounds for the treatment of cancer, autoimmune disorders and inflammation (2018-02-20),
8. 8299078 - Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin (2012-10-30),
9. 8263354 - Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin (2012-09-11),
10. 8168404 - Methods to treat cancer with 10-propargyl-10-deazaaminopterin and methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin (2012-05-01),
11. 7939530 - Treatment of lymphoma using 10-propargyl-10-deazaaminopterin and gemcitabine (2011-05-10),
12. 7622470 - Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin (2009-11-24),

Title: The Innovative Journey of Owen Anthony O'Connor

Introduction: Owen Anthony O'Connor, a talented inventor hailing from Scarsdale, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Owen Anthony O'Connor holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Owen Anthony O'Connor has worked with leading tech companies to bring his innovative ideas to life. He has been recognized for his exceptional problem-solving skills and creative approach to product development.

Collaborations: Throughout his career, Owen Anthony O'Connor has collaborated with top researchers, engineers, and designers to create cutting-edge solutions to complex challenges. His collaborative spirit and passion for innovation have led to the successful implementation of several groundbreaking projects.

Conclusion: Owen Anthony O'Connor's relentless pursuit of innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create a better tomorrow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…